• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biomed Rep . Clinical characteristics and predictors of death among hospitalized patients infected with SARS-CoV-2 in Sicily, Italy: A retrospectiv

tetano

Editor, Senior Moderator
Biomed Rep


. 2022 May;16(5):34.
doi: 10.3892/br.2022.1517. Epub 2022 Mar 1.
Clinical characteristics and predictors of death among hospitalized patients infected with SARS-CoV-2 in Sicily, Italy: A retrospective observational study


Federica Cosentino[SUP] 1 [/SUP], Vittoria Moscatt[SUP] 1 [/SUP], Andrea Marino[SUP] 1 [/SUP], Alessio Pampaloni[SUP] 1 [/SUP], Daniele Scuderi[SUP] 1 [/SUP], Manuela Ceccarelli[SUP] 1 [/SUP], Francesco Benanti[SUP] 1 [/SUP], Maria Gussio[SUP] 1 [/SUP], Licia Larocca[SUP] 1 [/SUP], Vincenzo Boscia[SUP] 1 [/SUP], Giovanni Vinci[SUP] 1 [/SUP], Aldo Zagami[SUP] 1 [/SUP], Anna Onorante[SUP] 1 [/SUP], Gaetano Lupo[SUP] 1 [/SUP], Salvatore Torrisi[SUP] 1 [/SUP], Silvana Grasso[SUP] 1 [/SUP], Roberto Bruno[SUP] 1 [/SUP], Carmelo Iacobello[SUP] 2 [/SUP], Salvatore Bonfante[SUP] 3 [/SUP], Luigi Guarneri[SUP] 4 [/SUP], Antonio Cascio[SUP] 5 [/SUP], Antonella Franco[SUP] 6 [/SUP], Rossella Fontana Del Vecchio[SUP] 6 [/SUP], Maria Antonietta Di Rosolini[SUP] 7 [/SUP], Alfredo Pulvirenti[SUP] 8 [/SUP], Damiano Larnè[SUP] 9 [/SUP], Giuseppe Nunnari[SUP] 9 [/SUP], Benedetto Maurizio Celesia[SUP] 1 [/SUP], Bruno Cacopardo[SUP] 1 [/SUP]



Affiliations

Abstract

Since late December 2019, severe acute respiratory syndrome coronavirus 2 has spread across the world, which resulted in the World Health Organization declaring a global pandemic. Coronavirus disease 2019 (COVID-19) presents a highly variable spectrum with regard to the severity of illness. Most infected individuals exhibit a mild to moderate illness (81%); however, 14% have a serious disease and 5% develop severe acute respiratory distress syndrome (ARDS), requiring intensive care support. The mortality rate of COVID-19 continues to rise across the world. Data regarding predictors of mortality in patients with COVID 19 are still scarce but are being actively investigated. The present multicenter retrospective observational study provides a complete description of the demographic and clinical characteristics, comorbidities and laboratory abnormalities in a population of 421 hospitalized patients recruited across eight infectious disease units in Southern Italy (Sicily) with the aim of identifying the baseline characteristics predisposing COVID-19 patients to critical illness or death. In this study, older age, pre-existing comorbidities and certain changes in laboratory markers (such as neutrophilia, lymphocytopenia and increased C-reactive protein levels) at the time of admission were associated with a higher risk of mortality. Male sex, on the other hand, was not significantly associated with increased risk of mortality. Symptoms such as fatigue, older age, a number of co-pathologies and use of continuous positive airway pressure were the most significant contributors in the estimation of clinical prognosis. Further research is required to better characterize the epidemiological features of COVID-19, to understand the related predictors of death and to develop new effective therapeutic strategies.

Keywords: SARS-CoV-2; epidemiological features; pandemic; predictors of death.
 
Back
Top Bottom